PREDICTION OF RESPONSE TO INTERFERON THERAPY BY SERUM LEVELS OF TYPE-IV COLLAGEN AND PROLYL HYDROXYLASE IN CHRONIC HEPATITIS-C

被引:0
作者
MIYABAYASHI, C
HIGUCHI, K
AIBA, N
SHIMIZU, Y
NAMBU, S
TAKAHARA, T
WATANABE, A
机构
[1] The Third Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama, 930-01
来源
INTERNATIONAL HEPATOLOGY COMMUNICATIONS | 1994年 / 2卷 / 03期
关键词
TYPE-IV COLLAGEN; PROLYL HYDROXYLASE; INTERFERON; CHRONIC HEPATITIS-C;
D O I
10.1016/0928-4346(94)90049-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We evaluated histological activity index (HAI) score and serum markers of liver fibrosis, type IV collagen (IV-C) and prolyl hydroxylase (PH), to analyze whether they are predictors of response to interferon (IFN) treatment for chronic hepatitis C. Efficacy of IFN therapy was evaluated in 16 patients. Mean serum levels of IV-C and PH before treatment in five responders were lower than those in 11 non-responders (not significant). Among seven patients whose IV-C values were less than 200 ng/ml and PH less than 80 ng/ml, five patients (71.4%) were responders. The response rate of these seven patients was significantly (P < 0.005) higher than that (0%) in the other nine patients. When patients were histologically divided by the total HAI scores, the response rate to IFN in patients with low HAI score (10 or less) was 71.4% (five of seven patients), while that in patients with high HAI score (more than 10) was 0%. The result that the response rate to IFN in patients with low serum IV-C and PH levels equaled that in patients with low HAI score suggests that the efficacy of IFN treatment may be predictable by measuring serum levels of IV-C and PH in patients with chronic hepatitis C.
引用
收藏
页码:156 / 160
页数:5
相关论文
共 50 条
  • [31] CLEARANCE OF SERUM HEPATITIS-C VIRUS-RNA AFTER INTERFERON THERAPY IN RELATION TO VIRUS GENOTYPE
    KANAI, K
    KAKO, M
    AIKAWA, T
    KUMADA, T
    KAWASAKI, T
    HATAHARA, T
    OKA, Y
    MIZOKAMI, M
    SAKAI, T
    IWATA, K
    OKAMOTO, H
    MAYUMI, M
    LIVER, 1995, 15 (04): : 185 - 188
  • [32] Quantitative analysis of interferon alpha/beta receptor mRNA in the liver of patients with chronic hepatitis C: Correlation with serum hepatitis C virus RNA levels and response to treatment with interferon
    Yatsuhashi, H
    Yamasaki, K
    Aritomi, T
    DelCarmen, PM
    Inoue, O
    Koga, M
    Yano, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 12 (06) : 460 - 467
  • [33] CHOICE OF APPROPRIATE END-POINTS OF RESPONSE TO INTERFERON THERAPY IN CHRONIC HEPATITIS-C VIRUS-INFECTION
    DAVIS, GL
    LAU, JYN
    JOURNAL OF HEPATOLOGY, 1995, 22 : 110 - 114
  • [34] NEUTRALIZING ANTIBODIES TO RECOMBINANT ALPHA-INTERFERON AND RESPONSE TO THERAPY IN CHRONIC HEPATITIS-C VIRUS-INFECTION
    MILELLA, M
    ANTONELLI, G
    SANTANTONIO, T
    CURRENTI, M
    MONNO, L
    MARIANO, N
    ANGARANO, G
    DIANZANI, F
    PASTORE, G
    LIVER, 1993, 13 (03): : 146 - 150
  • [35] Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C
    Ueno, T
    Inuzuka, S
    Sata, M
    Koh, H
    Tamaki, S
    Kin, M
    Sugawara, H
    Sakata, R
    Torimura, T
    Tanikawa, K
    HEPATO-GASTROENTEROLOGY, 1995, 42 (05) : 522 - 527
  • [36] Liver iron influences the response to interferon alpha therapy in chronic hepatitis C
    Fargion, S
    Fracanzani, AL
    Sampietro, M
    Molteni, V
    Boldorini, R
    Mattioli, M
    Cesana, B
    Lunghi, G
    Piperno, A
    Valsecchi, C
    Fiorelli, G
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1997, 9 (05) : 497 - 503
  • [37] Serum levels of tyrosine decrease with sustained virological response in patients with chronic hepatitis C treated by interferon-based therapy
    Shinohara, Mie
    Koji, Ishii
    Michio, Kogame
    Wakui, Noritaka
    Ikehara, Takashi
    Masao, Shinohara
    Nagai, Hidenari
    Watanabe, Manabu
    Igarashi, Yoshihiro
    Sumino, Yasukiyo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 203 - 204
  • [38] Significance of serum ribavirin concentration in combination therapy of interferon and ribavirin for chronic hepatitis C
    Arase, Y
    Ikeda, K
    Tsubota, A
    Suzuki, F
    Suzuki, Y
    Saitoh, S
    Kobayashi, M
    Akuta, N
    Someya, T
    Hosaka, T
    Sezaki, H
    Kobayashi, M
    Kumada, H
    INTERVIROLOGY, 2005, 48 (2-3) : 138 - 144
  • [39] INTERFERON THERAPY FOR PATIENTS MORE THAN 60 YEARS OF AGE WITH CHRONIC HEPATITIS-C
    HORIIKE, N
    MASUMOTO, T
    NAKANISHI, K
    MICHITAKA, K
    KUROSE, K
    OHKURA, I
    ONJI, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1995, 10 (03) : 246 - 249
  • [40] EFFICACY OF INTERFERON THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C - COMPARISON BETWEEN NONDRINKERS AND DRINKERS
    OKAZAKI, T
    YOSHIHARA, H
    SUZUKI, K
    YAMADA, Y
    TSUJIMURA, T
    KAWANO, K
    YAMADA, Y
    ABE, H
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 (11) : 1039 - 1043